| Literature DB >> 26515616 |
Shanshan Li1, Junyang Wang2, Xiao Li3, Shouliang Yin4, Weishan Wang5, Keqian Yang6.
Abstract
BACKGROUND: Streptomycetes attract a lot of attention in metabolic engineering and synthetic biology because of their well-known ability to produce secondary metabolites. However, the available constitutive promoters are rather limited in this genus.Entities:
Mesh:
Year: 2015 PMID: 26515616 PMCID: PMC4625935 DOI: 10.1186/s12934-015-0351-0
Source DB: PubMed Journal: Microb Cell Fact ISSN: 1475-2859 Impact factor: 5.328
Fig. 1Number of genes with constant expression profiles in S. coelicolor M145. The Venn diagram indicates the number of stably expressed genes based on the time-series transcriptome of M145 cultivated in different conditions
Fig. 2Rational selection of constitutive promoters in S. coelicolor. a Flow chart of the selection of constitutive promoters. b Transcript levels of genes with stable expression profiles after primary identification (941, black circles) and rational selection (166, blue dots). The red dots indicated genes whose promoters were selected for experiment validation. c The relative strengths of the 166 putative constitutive promoters based on RNA-Seq. The relative strengths of these promoters were reflected by the reads per kilobase per million mapped reads (RPKM) values of their downstream genes. The strength of the promoter of sco0119, which had the lowest RPKM value, was set to one. The red column indicates the experimentally tested constitutive promoters
Fig. 3Evaluation of the selected promoters using a GFP reporter. a Fluorescence intensities were determined in S. coelicolor M1146 derivatives with different promoters. b Fluorescence intensities were determined in S. venezuelae WVR2006 derivatives with different promoters. c Fluorescence intensities were determined in S. albus J1074 derivatives with different promoters. “Control” indicates strains with a promoterless GFP reporter. The ermE* promoter was tested in different Streptomyces species for comparison. The values are means ± standard deviation (SD) from three independent experiments. Data obtained from different growth stages of each strain were not statistically significant
Fig. 4Real-time RT-qPCR assays of the selected promoters. a The relative mRNA of gfp controlled by different promoters in S. coelicolor M1146. b The relative mRNA of gfp controlled by different promoters in S. venezuelae WVR2006. c The relative mRNA of gfp controlled by different promoters in S. albus J1074. The values are means ± SD from three independent experiments. Data obtained from different growth stages of each strain were not statistically significant
Fig. 5Correlations among data related to promoter strengths obtained by GFP reporter, real-time RT-qPCR, and RNA-Seq. a The positive linear relationships of data obtained in S. coelicolor M1146 derivatives. b The positive linear relationships of data obtained in S. venezuelae WVR2006 derivatives. c The positive linear relationships of data obtained in S. albus J1074 derivatives. Black dots in the three-dimensional spaces indicate the overall relationship of promoter strengths reflected by different approaches. The red, green, and blue dots scattered in the three different planes indicate the relationships of promoter strengths measured by any two approaches among the three approaches. For each promoter, the data were the averages of strengths generated by three different approaches. R 2 was the linear regression coefficient
Fig. 6Engineering of S. venezuelae ISP5230 using constitutive promoters with different strengths to produce jadomycin B. a Diagram for the construction of S. venezuelae ISP5230 derivatives with different constitutive promoters by single-crossover recombination. b Production of jadomycin B driven by different promoters. “Control” indicates that there was no promoter upstream of jadJ. “ND” means that jadomycin B was not detected. The values are means ± SD from three independent experiments
Strains and plasmids used in this work
| Name | Description | Source |
|---|---|---|
|
| ||
| JM109 | General cloning host for plasmid manipulation | Novagen |
| ET12567/PUZ8002 | Donor strain for conjugation between | [ |
|
| ||
| M145 | The model organism of | [ |
| M1146 | Derivative of M145, completely lacks the biosynthetic clusters of Act, Red, CDA and yCPK | [ |
|
| ||
| ISP5230 | Wild-type strain for jadomycin B production | [ |
| WVR2006 | Jadomycin biosynthetic gene cluster deletion mutant | [ |
|
|
| [ |
| Plasmids | ||
| pIJ8660 | Containing the reporter gene | [ |
| pDR4-E | Containing | [ |
| pIMermE* | Insert | This work |
| pIM4503 | Replace | This work |
| pIM4508 | Replace | This work |
| pIM6740 | Replace | This work |
| pIM3410 | Replace | This work |
| pIM4658 | Replace | This work |
| pIM2468 | Replace | This work |
| pIM2074 | Replace | This work |
| pIM5768 | Replace | This work |
| pLN0 | Remove the elements for site-specific recombination of pIMermE* | This work |
| pLNermE* | Insert 5′ end of | This work |
| pLNsco6740p | Replace | This work |
| pLNsco5768p | Replace | This work |
| pLNsco2074p | Replace | This work |
| pLNsco2468p | Replace | This work |